Conjunctival disorder

This trial tests a new antibiotic eye drop called SUM-191 for bacterial conjunctivitis (pink eye). It has three parts: first, healthy volunteers get a single dose to check safety; second, healthy volunteers get multiple doses for 6 days; third, patients with pink eye get the drop…

This study tests whether tofacitinib, a drug already used for rheumatoid arthritis, is safe and helpful for people with Sjogren's disease. About 60 adults with mild-to-moderate Sjogren's will take the pill twice daily for 28 weeks. Researchers will track side effects and measure …

This study tests a personalized treatment for advanced melanoma using a patient's own immune cells, called tumor-infiltrating lymphocytes (TIL), which are boosted with a protein called CD40L. After a short course of chemotherapy to make room, the enhanced cells are infused back a…

This study tests whether Miebo eye drops, used for one month before and 1.5 months after LASIK surgery, can reduce dry eye symptoms in people who already have dry eye disease. One hundred adults will use the drops four times daily. The goal is to see if eye dryness after surgery …

This study tests a prescription eye drop called Vevye (cyclosporine 0.1%) in 48 adults with meibomian gland dysfunction (MGD), a common cause of dry, burning eyes. Participants use the drops twice daily for 24 weeks, and researchers measure changes in eye symptoms, gland function…

This study tests a temporary magnetic device designed to help people with paralytic lagophthalmos—a condition where the eyelid cannot close fully—protect their eyes from dryness, ulcers, and vision loss. The device uses small magnets placed on the eyelids to gently hold them shut…

This early-stage trial tests an investigational drug called ABBV-319 in 36 adults with lupus or Sjogren's disease. The drug is designed to deplete overactive B cells, which are part of the immune system that cause inflammation and symptoms. Participants receive two doses by IV, 2…

This study tests whether adding diquafosol eye drops to standard treatment helps people with moderate-to-severe vernal keratoconjunctivitis (a serious eye allergy). About 94 participants aged 6 and older will receive either diquafosol plus cyclosporine or cyclosporine alone. Rese…

This phase 3 trial tests whether fusidic acid 1% eye drops can cure bacterial conjunctivitis (pink eye) better than a placebo. About 400 adults and children with confirmed bacterial infection will receive either the antibiotic or placebo drops for a short time. The study measures…

This early-phase trial is testing a personalized vaccine made from each patient's unique tumor mutations. The vaccine is given along with an immune booster (poly ICLC) to help the body's T cells attack the cancer. The study includes up to 25 adults with advanced melanoma, breast …

This study tests whether stingless bee honey (Kelulut honey) can help young people with juvenile open-angle glaucoma. Sixty participants will either take 30 grams of honey daily for three months or receive no honey. Researchers will measure changes in inflammation, eye nerve thic…

This study tests a new surgical method for pterygium, a growth on the eye's surface. Instead of cutting the growth out completely, surgeons move it to a different spot and stitch it down, preserving healthy tissue. The goal is to see if this lowers the chance of the pterygium com…

This study tests whether transplanting healthy bacteria from the eye's surface can help people with moderate to severe dry eye. Forty participants will either receive the bacteria transplant or a fake procedure. Researchers will measure changes in eye discomfort and surface damag…

This study tests special eye drops made with stem cells to see if they can help people with dry eye disease and cataracts. Researchers will give 300 adults these drops three times a day for 12 weeks. They will check if the drops improve tear film, reduce symptoms, and clear up th…

This study tests a smartphone app that uses artificial intelligence to detect 16 different eye diseases from photos taken with the phone. The AI works entirely on the device, so no internet is needed. Researchers will compare its accuracy to eye doctors and see if non-medical use…

This study compares a next-generation eye scanner (Intalight Dream OCT) with the current standard device (Heidelberg Spectralis OCT) to see which provides better images of eye tumors. Researchers will enroll 60 adults with ocular tumors and evaluate image quality and field of vie…

This study tests a new AI algorithm that screens for severe dry eye disease by analyzing images of the cornea. Researchers will enroll 200 adults already diagnosed with dry eye to see if the AI can better identify cases needing specialist care compared to a standard symptom quest…

This study aims to improve how doctors detect, classify, and treat irregular corneas caused by conditions like keratoconus, dry eye, and corneal scars. Researchers will use a special imaging device called optical coherence tomography (OCT) to get detailed measurements of the corn…

This study tests a new eye drop called HUC1-394 in 150 adults with moderate to severe dry eye disease. Participants will use the drops or a placebo for a period to see if the drug reduces eye surface damage and improves symptoms. The goal is to find the best dose and frequency.

This study compares three different over-the-counter lubricating eye drops in people with dry eye disease. Researchers will measure how well each drop is tolerated, how much it improves symptoms like discomfort and blurry vision, and its effect on daily visual function. The trial…

This study tests a new eye drop called DFL24498 in people with dry eye disease. About 417 adults will use the drops four times a day for 12 weeks. Researchers will check if the drops improve eye surface health and reduce dryness symptoms compared to a placebo.

This study tests two experimental drugs (REGN5713 and REGN5715) given alone or together to reduce eye allergy symptoms caused by birch pollen. About 350 adults with birch pollen allergy will receive the drugs or a placebo and then be exposed to pollen in a controlled setting. The…

This study tests whether a protein-based eye drop (rhPRG4) can safely relieve dry eye symptoms in people with Sjögren's syndrome. About 80 adults will receive either the active drops or a placebo for 28 days. The main goal is to see if the drops can clear corneal staining, a sign…

This study is testing two versions of Tears Naturale lubricating eye drops—one with preservatives and one without—in 120 people with mild to moderate dry eye disease. Participants will stop using their usual artificial tears and use only the study drops for the duration of the tr…

This early study tests eye drops made from stem cell particles in 20 adults with dry eye disease. Participants use the drops four times daily for four weeks. Researchers track safety and symptom changes like eye staining and tear film stability.

This study tests whether a new eye drop, BUFY01, works as well as an existing one, SVS20, for people with dry eye disease. About 80 participants will use one of the two drops daily for three months. Researchers will check eye health and ask about symptoms to see if the treatments…

This study tests whether a new treatment (BUFY02) works as well as an existing one (TRB02) for dry eye disease. About 80 adults with dry eye for at least 3 months will use the assigned eye drops daily for 3 months. Researchers will check eye health and symptoms to see if both tre…

This early study tests a new spring made from surgical stitches to help people with facial nerve palsy close their eyelid. The spring is placed under the skin near the eyelid center, without attaching to bone. Ten adults who cannot blink due to nerve damage will try it, aiming to…

This study tests whether rinsing the inner eyelids and eye surface with a special device can lower inflammation and improve symptoms in people with dry eye disease. Researchers will measure changes in a marker of inflammation called MMP-9 in 33 participants. The goal is to see if…

This study tests whether licaminlimab eye drops can reduce eye discomfort in people with dry eye disease who have a specific gene variant. About 160 participants will use the drops three times daily for 29 days. The goal is to see if this targeted approach works better than a pla…

This study tests a varenicline nasal spray for treating dry eye and meibomian gland dysfunction. Researchers will measure changes in tear film thickness and stability in 65 adults with mild to moderate symptoms. The goal is to see if the spray improves eye comfort and gland funct…

This study tests a new lubricating eye drop called ABR2 in 40 adults with dry eye syndrome. The goal is to check if the drop is safe and tolerable when used for up to 28 days. Participants first receive a single drop in one eye, then use the drop at least twice daily for a month.…

This study compares two preservative-free eye drops, Artelac Complete MDO and VISMED MULTI, for treating moderate to severe dry eye disease. About 160 adults who have used tear substitutes for at least a month will use one of the two drops for 90 days. Researchers will measure ch…

This study tests a disposable silicone device that clips onto eyeglasses to trap moisture around the eyes. Thirty-five adults with mild to moderate dry eye will wear it for two hours. Researchers will measure tear film stability, tear volume, and symptom changes before and after …

This study compares a clinic-based thermal device (MiBo Thermoflo) to standard warm compresses for treating dry eye caused by meibomian gland dysfunction. About 42 adults who haven't improved with warm compresses will be randomly assigned to either three sessions of MiBo therapy …

This study is testing VEVYE eye drops (cyclosporine 0.1%) in 50 adults with dry eye disease who also have a neuro-ophthalmic condition, such as neurotrophic keratitis. Participants use the drops twice daily for 6 months. Researchers will measure changes in corneal staining and sy…

This study tests whether placing a tiny plug in the upper tear duct can further relieve dry eye symptoms in people who already have a plug in the lower tear duct. Researchers will follow 36 adults with aqueous-deficient dry eye for 6 months, measuring eye comfort and tear film ch…

This study tests whether a special ingredient called trehalose, found in some artificial tears, can improve the eye's natural barrier function in people with dry eye disease. About 30 adults with moderate-to-severe dry eye will use the drops for one month. Researchers will measur…

This trial tests whether a non-invasive radiofrequency device (Thermage FLX) plus eyelid gland expression can improve tear film stability better than gland expression alone in people with dry eye that hasn't responded to standard treatments. About 112 adults with moderate to seve…

This study compares two lubricating eye drops—Systane PRO PF and Thealoz Duo—to see which one better relieves dry eye symptoms. About 100 adults with dry eye will use each drop for 4 weeks, one twice a day and the other four times a day. The goal is to find out if they work equal…

This study looks at whether Systane COMPLETE artificial tears can improve dry eye symptoms and help doctors better predict cataract surgery outcomes. About 140 cataract patients with dry eye will use the drops before and after surgery. Researchers will measure changes in eye shap…

This study tests whether using Systane COMPLETE eye drops before cataract surgery can improve dry eye symptoms and help with surgical planning. About 150 adults aged 20-85 with dry eye who need cataract surgery will use the drops regularly before their operation. Researchers will…

This study tests whether a product called Lacrifill can help people who wear contact lenses but get dry, uncomfortable eyes. About 30 adults who currently can't wear their lenses for long periods will use Lacrifill for 2-3 months. Researchers will check if it improves comfort, ex…

This study compares two eye drops—SYSTANE PRO and MIEBO—to see if SYSTANE PRO works as well as MIEBO for treating dry eye disease. About 260 adults with moderate dry eye will use one of the two drops for one month. The main goal is to measure changes in dry eye symptoms using a s…

This study is testing two new artificial tear formulas to see if they are safe and well-tolerated in people with moderate dry eye disease. Researchers will monitor for side effects and eye health in 148 participants who already use artificial tears. The goal is to find better opt…

This Phase 2 trial tests a new eye drop that combines two active ingredients—lifitegrast and perfluorohexyloctane—for people with dry eye disease. About 423 adults will use the drops twice daily for 4 weeks. Researchers will measure changes in eye surface staining and symptom sco…

This study tests whether a device called IRIDIUM GARZE can help ease eye discomfort in people with blepharitis or blepharoconjunctivitis. About 80 adults in Italy will use the device four times a day for 28 days alongside their usual treatment. The main goal is to see if eye symp…

This study tests a new eye drop (FBV_01) that combines an extra ingredient with hyaluronic acid for people with moderate-to-severe dry eye. About 74 adults will use the drop four times a day for 30 days. Researchers will compare it to hyaluronic acid alone to see if the combo is …

This study tests whether a standard cosmetic treatment for eye wrinkles (Tixel) can also improve symptoms and signs of dry eye disease. 36 adults with mild to moderate wrinkles and dry eyes will receive either real Tixel or a sham treatment. The goal is to see if the treatment is…

This study looks at whether lifestyle changes can improve dry eyes in obese women with polycystic ovary syndrome (PCOS). Researchers will measure tear production and eye comfort in 40 women before and after the program. The goal is to see if weight loss and healthy habits can eas…

This study tests whether TheaLoz Duo eyedrops can protect the eyes of people who play handheld console or computer games for at least 2 hours daily. 28 participants with mild dry eye symptoms will use the drops for one month and no drops for another month, in random order. Resear…

This study tests an experimental eye drop (rhPRG4) to see if it safely eases dry eye symptoms in people with ocular graft-versus-host disease (oGVHD), a complication after bone marrow transplant. About 15 adults with moderate to severe dry eye will receive both the active drop an…

This study compares red and blue light therapy masks for people with dry eye disease, meibomian gland dysfunction, and blepharitis (eyelid inflammation). Thirty-six participants will receive three light treatments, one week apart, and be followed for one month after the last sess…

This study tests whether Vit-A-Vision, an eye ointment used up to three times daily, can improve dry eye symptoms like burning and irritation. About 77 adults with dry eye disease will use the ointment for 30 days. Researchers will measure tear film stability and symptom scores t…

This study is testing whether eye drops made from a patient's own blood serum can safely relieve symptoms of moderate-to-severe dry eye that hasn't improved with artificial tears. Researchers will collect a blood sample from each of the 70 participants, process it into drops, and…

This study tests whether taking Kelulut honey daily for one month can reduce dry eye and allergy symptoms in adults with allergic conjunctivitis. Participants will take either honey or a placebo syrup and continue their usual eye treatments. Researchers will measure eye moisture,…

This study tests whether a drug called TRYPTYR (Acoltremon) can improve quality of life and work ability in adults with chronic dry eye disease. About 40 participants who are unhappy with their current treatment will use the eye drops for one month. Researchers will measure chang…

This early study tests a new eye drop called JN002 in 30 adults with dry eye disease. Participants will use the drops three times a day for 28 days. The goal is to see if the drops are safe and if they improve symptoms and eye surface health compared to a placebo.

This study compares two stitching methods used during surgery for pterygium, a growth on the eye's surface. Forty people with primary pterygium will be randomly assigned to receive either a new compression continuous suture or the traditional suture technique. The goal is to see …

This study tests a new eye drop called TL-925 for seasonal allergic conjunctivitis (eye allergies). About 60 adults with a history of eye allergies will receive either the active eye drop or a placebo. Researchers will measure how well it reduces itching and redness after exposur…

This study is testing a new eye drop that combines trehalose, sodium hyaluronate, and NAAGA without preservatives. It will enroll 30 adults with dry eye disease who are either new to treatment or unhappy with their current drops. Over 6 months, researchers will track changes in s…

This study tests a gel placed in the tear ducts before cataract surgery to see if it helps dry eye symptoms. Sixty adults with dry eye will receive the gel and be followed for up to 5 months. The main goal is to measure tear film stability, a key sign of eye moisture.

This study tests a device called Rexon-Eye that uses low-level electrical current to treat dry eye disease. Researchers will also analyze tear proteins to see how they change with treatment. The trial involves 75 adults with dry eye and aims to understand both the device's effect…

This study tests whether a new eye drop called VSJ-110 can safely ease dry eye symptoms. About 160 adults will use either the active drops or a placebo for eight weeks. Researchers will check for changes in eye surface damage, tear production, and discomfort.

This study tests whether Kera Sol eye drops can reduce dry eye symptoms in the two weeks after LASIK surgery. About 60 adults having LASIK in both eyes will use the drops and be monitored for changes in corneal staining and comfort. The goal is to see if the drops help manage tem…

This study is testing whether eye drops made from cord blood plasma can relieve symptoms of moderate to severe dry eye disease better than standard artificial tears. Researchers will compare the cord blood drops combined with cyclosporine to a control treatment of hyaluronic acid…

This study looks at whether a new cyclosporin eye drop (Vevizye®) can reduce inflammation and dryness in people with moderate to severe dry eye disease who still have symptoms after using artificial tears. About 25 adults with chronic dry eye and visible eye redness will use the …

This study screens people with eye diseases to see if they can join other research studies at the National Eye Institute. No treatment is given. Participants undergo eye exams, blood tests, and other procedures to diagnose or evaluate their condition. The goal is simply to determ…

This study looks at whether dry eye disease affects the accuracy of corneal measurements needed for cataract surgery planning. 400 cataract patients will be divided into those with and without dry eye. Those with dry eye will use sodium hyaluronate eye drops for two weeks. Resear…

This study tests a special camera that takes super-detailed pictures of the back of the eye (the retina). The goal is to see if this technology can find eye diseases earlier than standard methods. Up to 1,000 people aged 12 and older, with or without eye disease, will have their …

This study is looking at whether GLP-1 receptor agonists—drugs used for type 2 diabetes and obesity—can also improve dry eye disease. Researchers will measure changes in tear stability and eye surface health in 100 patients who have not taken these drugs before. The goal is to un…

This study aims to learn more about eye diseases by observing and providing standard care to up to 1,000 people over 5 years. Participants receive regular eye exams, tests, and treatments as needed. The goal is to better understand how eye diseases progress and are inherited, not…

This study will enroll 50 people with dry eye disease to compare three different devices that measure the thickness of the tear film's lipid layer. Researchers want to see which device gives the most consistent readings and which one best matches other signs of dry eye. The goal …

This study will test whether 0.1% cyclosporine A eye drops can change the number and behavior of immune cells on the eye's surface in people with dry eye disease. Researchers will use a special microscope to watch these cells move over 12 weeks and compare the drops to a lubricat…

This study collects tear samples from 300 people with dry eye, infectious keratoconjunctivitis, mucous membrane pemphigoid, or allergic conjunctivitis. Researchers will analyze the proteins and metabolites in tears to create a unique fingerprint for each condition. The goal is to…

This study collects information and biological samples from 150 adults who have had cancer therapy and now have eye complications, such as dry eye or graft-versus-host disease. Researchers will track their eye health over time using standard exams and lab tests. The goal is to le…

This study tests whether artificial intelligence can create simple summaries of eye doctor notes that are easier for patients to understand. About 460 English-speaking adults receiving eye care will get either standard notes or notes plus an AI-generated plain language summary. P…

This study looks at whether the amount of iron in tears is linked to how severe dry eye disease is. Researchers will collect tear samples from 52 people with and without dry eye and compare iron levels to standard eye tests and symptom scores. The goal is to find a new way to dia…

This study collects eye fluid, cells, and blood samples from 150 adult cancer patients who have dry eye disease after a stem cell transplant (graft-versus-host disease). Researchers will analyze these samples to find risk factors, markers, and possible treatment targets. The goal…

This study tests a new 4D microscope-integrated OCT system for the first time in people during eye surgery. Researchers want to see if the system is easy to use, safe, and can clearly show eye structures. Five adults having eye surgery will take part. The goal is to improve imagi…

This study looks at how low-level light therapy changes tear proteins in people with dry eye disease. Researchers want to understand how the therapy works and find markers that show who will respond well. About 30 adults will have their tears tested before and after treatment.

This study looks at how to better diagnose and treat dry eye before cataract surgery to help people see better after the operation. About 110 adults with dry eye will be followed to find the best ways to prepare the eye surface. The goal is to create clear guidelines that eye doc…

This study looks at whether closing your eyes for 3 minutes can improve the quality of a key eye measurement (keratometry) used before cataract surgery. The measurement is often less accurate in people with dry eye. Researchers will compare measurements taken before and after eye…

This study is looking at tiny changes on the surface of eye cells in people with severe dry eye. Researchers will compare these cells before and after treatment starts, and also compare them to people without dry eye. The goal is to better understand what happens in the disease, …

This study gathers standard eye movement and pupil data from 200 healthy volunteers, children, and people with eye or brain conditions using a VR headset called neos™. The headset shows images and tracks where participants look, how their pupils react, and how their eyes move. Th…

This study tests a high-resolution imaging system to see tiny structures in the eye that routine tools cannot detect. Researchers will scan 1,200 people with various eye conditions and healthy volunteers. The goal is to better understand diseases like glaucoma, diabetes, and reti…

This pilot study explores whether people with dry eye disease can complete surveys and collect eye fluid samples from home, instead of visiting a clinic. Researchers aim to see if this remote method is practical and can help include more diverse participants in future studies. 90…

This study tests a new, more comfortable eye camera (WiSLO) designed for children and adults. Researchers want to see if it takes better pictures and is less bothersome than current cameras. About 42 people with or without eye disease will have their eyes photographed with both t…

This study looks at whether using eyeliner can lead to dry eyes. Researchers will compare tear production, tear film stability, and tear composition between 80 people who use eyeliner regularly and those who don't. The goal is to understand if eyeliner ingredients change tears an…

This study looks at whether low-level light therapy (LLLT) warms the eyelids differently in people with various skin pigmentation levels who also have dry eye or meibomian gland disease. Forty adults will receive three 15-minute sessions over 1-2 weeks. Researchers will measure e…